Surgical management of scrotal lymphedema using local flaps
Halperin, T. J., S. A. Slavin, A. F. Olumi, and L. J. Borud. 2007. Surgical Management of Scrotal Lymphedema Using Local Flaps.
Search
Search results
104 results found
MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L)
Li, W., X. Zhang, and A. F. Olumi. 2007. MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating C-Fos/C-Jun Heterodimers and Repressing C-FLIP(L).
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
Zhang, L., X. Zhang, G. W. Barrisford, and A. F. Olumi. 2007. Lexatumumab (TRAIL-Receptor 2 MAb) Induces Expression of DR5 and Promotes Apoptosis in Primary and Metastatic Renal Cell Carcinoma in a Mouse Orthotopic Model.
Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia
Wang, Z., and A. F. Olumi. 2011. Diabetes, Growth Hormone-Insulin-Like Growth Factor Pathways and Association to Benign Prostatic Hyperplasia.
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer
Aizer, A. A., J. J. Paly, A. L. Zietman, P. L. Nguyen, C. J. Beard, S. K. Rao, I. D. Kaplan, et al. 2012. Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer.
Models of care and NCCN guideline adherence in very-low-risk prostate cancer
Aizer, A. A., J. J. Paly, A. L. Zietman, P. L. Nguyen, C. J. Beard, S. K. Rao, I. D. Kaplan, et al. 2013. Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer.
Inhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformation
Yang, H., X. Chen, X. Wang, Y. Li, S. Chen, X. Qian, R. Wang, et al. 2014. Inhibition of PP2A Activity Confers a TRAIL-Sensitive Phenotype During Malignant Transformation.
Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells
Ge, R., Z. Wang, S. Wu, Y. Zhuo, A. G. Otsetov, C. Cai, W. Zhong, C. L. Wu, and A. F. Olumi. 2015. Metformin Represses Cancer Cells via Alternate Pathways in N-Cadherin Expressing Vs. N-Cadherin Deficient Cells.
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Liu, D., J. E. Shoag, D. Poliak, R. S. Goueli, V. Ravikumar, D. Redmond, A. Vosoughi, et al. 2020. Integrative Multiplatform Molecular Profiling of Benign Prostatic Hyperplasia Identifies Distinct Subtypes.
Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer
Estevez, A., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, J. Bellmunt, A. F. Olumi, H. Rayala, and B. Gershman. 2023. Disparities in the Prevalence and Management of High-Risk Non-Muscle Invasive Bladder Cancer.